Loading…

Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction

Background It is well established that left ventricular systolic dysfunction (LVSD), as marked by reduced left ventricular ejection fraction (LVEF), notably worsens the prognosis of ST-elevation myocardial infarction (STEMI). However, the link between cardiometabolic risk markers and LVSD seems uncl...

Full description

Saved in:
Bibliographic Details
Published in:BMC cardiovascular disorders 2022-05, Vol.22 (1)
Main Authors: Mahdavi-Roshan, Marjan, Ghorbani, Zeinab, Gholipour, Mahboobeh, Salari, Arsalan, Savar Rakhsh, Amir, Kheirkhah, Jalal
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page
container_title BMC cardiovascular disorders
container_volume 22
creator Mahdavi-Roshan, Marjan
Ghorbani, Zeinab
Gholipour, Mahboobeh
Salari, Arsalan
Savar Rakhsh, Amir
Kheirkhah, Jalal
description Background It is well established that left ventricular systolic dysfunction (LVSD), as marked by reduced left ventricular ejection fraction (LVEF), notably worsens the prognosis of ST-elevation myocardial infarction (STEMI). However, the link between cardiometabolic risk markers and LVSD seems unclear. This study aimed to investigate the differences in variables affecting reduced LVEF in STEMI patients. Methods In the current retrospective study, 200 consecutive STEMI patients were enrolled between April 2016 to January 2017. Analysis of serum parameters, anthropometric evaluation, and echocardiography was performed after admission. The participants were categorized according to LVEF levels as follows: group1 (normal: 50-70%, n = 35), group2 (mildly reduced: 40-49%, n = 48); group3 (moderately reduced: 30-39%, n = 94) and group4 (severely reduced: < 30%, n = 23). Between-group comparisons were made using the Kruskal-Wallis test. Results Overall, of 200 STEMI patients with a mean age of 62 years, 27%(n = 54) were females. The median of BMI of patients in group4 (31.07 kg/m.sup.2) was significantly higher than group3 (26.35 kg/m.sup.2), group2 (25.91 kg/m.sup.2), and group1 (24.98 kg/m.sup.2; P value < 0.0001). Group4 patients showed significantly increased fasting blood sugar (FBS) than groups 1 (212.00, vs. 139.00 mg/dl; P value = 0.040). Patients in groups 1 and 2 exerted significantly elevated triglyceride levels than those in group4 (142.00, 142.50, and 95.00 mg/dl; P value = 0.001). WBC count, neutrophil%, and neutrophil to lymphocyte ratio among those in group1 (10,200/m.sup.3, 70.00%, and 2.92, respectively) were significantly lower than group4 (12,900/m.sup.3, 83.00%, and 5.47, respectively; P value < 0.05). Conclusion These findings highlight higher BMI, FBS, and leucocyte count linked to LVSD, probably through increasing the inflammation and reducing LVEF levels. More extensive studies are needed to clarify the clinical relevance of these results. Keywords: Hyperlipidemia, Overweight, Hyperglycemia, Echocardiography, Myocardial infection
doi_str_mv 10.1186/s12872-022-02660-3
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A703790406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A703790406</galeid><sourcerecordid>A703790406</sourcerecordid><originalsourceid>FETCH-LOGICAL-g676-a6b1c9a9bddfd02afca44b73349524008b27adda174ad7393079d5fa7a2734913</originalsourceid><addsrcrecordid>eNptjstqwzAQRUVpoWnaH-hK0LVTvSJZyxDSBwS6yd6M9QiKZQskO99fN-0iizIMcxjOXAahZ0pWlNbytVBWK1YR9tNSkorfoAUVilaMSXp7xffooZQTIVTVRC9QsztDnGAMacDJYwPZhtS7EdoUg8E5lA73kDuXC45h6JzFY8LZ2cnMGJ0f8dkNYw5mipCxOzlzyfIZLvCI7jzE4p7-5hId3naH7Ue1_3r_3G721VEqWYFsqdGgW2u9JQy8ASFaxbnQayYIqVumwFqgSoBVXHOitF17UMDU7FC-RC-_sUeIrgmDT-P8QB-KaTaKcKWJIHK2Vv9Yc1nXB5MG58O8vzr4BoKrZzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction</title><source>PubMed Central(OA)</source><source>Publicly Available Content Database (ProQuest Open Access資料庫)</source><creator>Mahdavi-Roshan, Marjan ; Ghorbani, Zeinab ; Gholipour, Mahboobeh ; Salari, Arsalan ; Savar Rakhsh, Amir ; Kheirkhah, Jalal</creator><creatorcontrib>Mahdavi-Roshan, Marjan ; Ghorbani, Zeinab ; Gholipour, Mahboobeh ; Salari, Arsalan ; Savar Rakhsh, Amir ; Kheirkhah, Jalal</creatorcontrib><description>Background It is well established that left ventricular systolic dysfunction (LVSD), as marked by reduced left ventricular ejection fraction (LVEF), notably worsens the prognosis of ST-elevation myocardial infarction (STEMI). However, the link between cardiometabolic risk markers and LVSD seems unclear. This study aimed to investigate the differences in variables affecting reduced LVEF in STEMI patients. Methods In the current retrospective study, 200 consecutive STEMI patients were enrolled between April 2016 to January 2017. Analysis of serum parameters, anthropometric evaluation, and echocardiography was performed after admission. The participants were categorized according to LVEF levels as follows: group1 (normal: 50-70%, n = 35), group2 (mildly reduced: 40-49%, n = 48); group3 (moderately reduced: 30-39%, n = 94) and group4 (severely reduced: &lt; 30%, n = 23). Between-group comparisons were made using the Kruskal-Wallis test. Results Overall, of 200 STEMI patients with a mean age of 62 years, 27%(n = 54) were females. The median of BMI of patients in group4 (31.07 kg/m.sup.2) was significantly higher than group3 (26.35 kg/m.sup.2), group2 (25.91 kg/m.sup.2), and group1 (24.98 kg/m.sup.2; P value &lt; 0.0001). Group4 patients showed significantly increased fasting blood sugar (FBS) than groups 1 (212.00, vs. 139.00 mg/dl; P value = 0.040). Patients in groups 1 and 2 exerted significantly elevated triglyceride levels than those in group4 (142.00, 142.50, and 95.00 mg/dl; P value = 0.001). WBC count, neutrophil%, and neutrophil to lymphocyte ratio among those in group1 (10,200/m.sup.3, 70.00%, and 2.92, respectively) were significantly lower than group4 (12,900/m.sup.3, 83.00%, and 5.47, respectively; P value &lt; 0.05). Conclusion These findings highlight higher BMI, FBS, and leucocyte count linked to LVSD, probably through increasing the inflammation and reducing LVEF levels. More extensive studies are needed to clarify the clinical relevance of these results. Keywords: Hyperlipidemia, Overweight, Hyperglycemia, Echocardiography, Myocardial infection</description><identifier>ISSN: 1471-2261</identifier><identifier>EISSN: 1471-2261</identifier><identifier>DOI: 10.1186/s12872-022-02660-3</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Blood cell count ; Body mass index ; Cardiovascular research ; Heart attack ; Left ventricular function ; Prognosis</subject><ispartof>BMC cardiovascular disorders, 2022-05, Vol.22 (1)</ispartof><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mahdavi-Roshan, Marjan</creatorcontrib><creatorcontrib>Ghorbani, Zeinab</creatorcontrib><creatorcontrib>Gholipour, Mahboobeh</creatorcontrib><creatorcontrib>Salari, Arsalan</creatorcontrib><creatorcontrib>Savar Rakhsh, Amir</creatorcontrib><creatorcontrib>Kheirkhah, Jalal</creatorcontrib><title>Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction</title><title>BMC cardiovascular disorders</title><description>Background It is well established that left ventricular systolic dysfunction (LVSD), as marked by reduced left ventricular ejection fraction (LVEF), notably worsens the prognosis of ST-elevation myocardial infarction (STEMI). However, the link between cardiometabolic risk markers and LVSD seems unclear. This study aimed to investigate the differences in variables affecting reduced LVEF in STEMI patients. Methods In the current retrospective study, 200 consecutive STEMI patients were enrolled between April 2016 to January 2017. Analysis of serum parameters, anthropometric evaluation, and echocardiography was performed after admission. The participants were categorized according to LVEF levels as follows: group1 (normal: 50-70%, n = 35), group2 (mildly reduced: 40-49%, n = 48); group3 (moderately reduced: 30-39%, n = 94) and group4 (severely reduced: &lt; 30%, n = 23). Between-group comparisons were made using the Kruskal-Wallis test. Results Overall, of 200 STEMI patients with a mean age of 62 years, 27%(n = 54) were females. The median of BMI of patients in group4 (31.07 kg/m.sup.2) was significantly higher than group3 (26.35 kg/m.sup.2), group2 (25.91 kg/m.sup.2), and group1 (24.98 kg/m.sup.2; P value &lt; 0.0001). Group4 patients showed significantly increased fasting blood sugar (FBS) than groups 1 (212.00, vs. 139.00 mg/dl; P value = 0.040). Patients in groups 1 and 2 exerted significantly elevated triglyceride levels than those in group4 (142.00, 142.50, and 95.00 mg/dl; P value = 0.001). WBC count, neutrophil%, and neutrophil to lymphocyte ratio among those in group1 (10,200/m.sup.3, 70.00%, and 2.92, respectively) were significantly lower than group4 (12,900/m.sup.3, 83.00%, and 5.47, respectively; P value &lt; 0.05). Conclusion These findings highlight higher BMI, FBS, and leucocyte count linked to LVSD, probably through increasing the inflammation and reducing LVEF levels. More extensive studies are needed to clarify the clinical relevance of these results. Keywords: Hyperlipidemia, Overweight, Hyperglycemia, Echocardiography, Myocardial infection</description><subject>Blood cell count</subject><subject>Body mass index</subject><subject>Cardiovascular research</subject><subject>Heart attack</subject><subject>Left ventricular function</subject><subject>Prognosis</subject><issn>1471-2261</issn><issn>1471-2261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjstqwzAQRUVpoWnaH-hK0LVTvSJZyxDSBwS6yd6M9QiKZQskO99fN-0iizIMcxjOXAahZ0pWlNbytVBWK1YR9tNSkorfoAUVilaMSXp7xffooZQTIVTVRC9QsztDnGAMacDJYwPZhtS7EdoUg8E5lA73kDuXC45h6JzFY8LZ2cnMGJ0f8dkNYw5mipCxOzlzyfIZLvCI7jzE4p7-5hId3naH7Ue1_3r_3G721VEqWYFsqdGgW2u9JQy8ASFaxbnQayYIqVumwFqgSoBVXHOitF17UMDU7FC-RC-_sUeIrgmDT-P8QB-KaTaKcKWJIHK2Vv9Yc1nXB5MG58O8vzr4BoKrZzA</recordid><startdate>20220514</startdate><enddate>20220514</enddate><creator>Mahdavi-Roshan, Marjan</creator><creator>Ghorbani, Zeinab</creator><creator>Gholipour, Mahboobeh</creator><creator>Salari, Arsalan</creator><creator>Savar Rakhsh, Amir</creator><creator>Kheirkhah, Jalal</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20220514</creationdate><title>Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction</title><author>Mahdavi-Roshan, Marjan ; Ghorbani, Zeinab ; Gholipour, Mahboobeh ; Salari, Arsalan ; Savar Rakhsh, Amir ; Kheirkhah, Jalal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g676-a6b1c9a9bddfd02afca44b73349524008b27adda174ad7393079d5fa7a2734913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood cell count</topic><topic>Body mass index</topic><topic>Cardiovascular research</topic><topic>Heart attack</topic><topic>Left ventricular function</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahdavi-Roshan, Marjan</creatorcontrib><creatorcontrib>Ghorbani, Zeinab</creatorcontrib><creatorcontrib>Gholipour, Mahboobeh</creatorcontrib><creatorcontrib>Salari, Arsalan</creatorcontrib><creatorcontrib>Savar Rakhsh, Amir</creatorcontrib><creatorcontrib>Kheirkhah, Jalal</creatorcontrib><jtitle>BMC cardiovascular disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahdavi-Roshan, Marjan</au><au>Ghorbani, Zeinab</au><au>Gholipour, Mahboobeh</au><au>Salari, Arsalan</au><au>Savar Rakhsh, Amir</au><au>Kheirkhah, Jalal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction</atitle><jtitle>BMC cardiovascular disorders</jtitle><date>2022-05-14</date><risdate>2022</risdate><volume>22</volume><issue>1</issue><issn>1471-2261</issn><eissn>1471-2261</eissn><abstract>Background It is well established that left ventricular systolic dysfunction (LVSD), as marked by reduced left ventricular ejection fraction (LVEF), notably worsens the prognosis of ST-elevation myocardial infarction (STEMI). However, the link between cardiometabolic risk markers and LVSD seems unclear. This study aimed to investigate the differences in variables affecting reduced LVEF in STEMI patients. Methods In the current retrospective study, 200 consecutive STEMI patients were enrolled between April 2016 to January 2017. Analysis of serum parameters, anthropometric evaluation, and echocardiography was performed after admission. The participants were categorized according to LVEF levels as follows: group1 (normal: 50-70%, n = 35), group2 (mildly reduced: 40-49%, n = 48); group3 (moderately reduced: 30-39%, n = 94) and group4 (severely reduced: &lt; 30%, n = 23). Between-group comparisons were made using the Kruskal-Wallis test. Results Overall, of 200 STEMI patients with a mean age of 62 years, 27%(n = 54) were females. The median of BMI of patients in group4 (31.07 kg/m.sup.2) was significantly higher than group3 (26.35 kg/m.sup.2), group2 (25.91 kg/m.sup.2), and group1 (24.98 kg/m.sup.2; P value &lt; 0.0001). Group4 patients showed significantly increased fasting blood sugar (FBS) than groups 1 (212.00, vs. 139.00 mg/dl; P value = 0.040). Patients in groups 1 and 2 exerted significantly elevated triglyceride levels than those in group4 (142.00, 142.50, and 95.00 mg/dl; P value = 0.001). WBC count, neutrophil%, and neutrophil to lymphocyte ratio among those in group1 (10,200/m.sup.3, 70.00%, and 2.92, respectively) were significantly lower than group4 (12,900/m.sup.3, 83.00%, and 5.47, respectively; P value &lt; 0.05). Conclusion These findings highlight higher BMI, FBS, and leucocyte count linked to LVSD, probably through increasing the inflammation and reducing LVEF levels. More extensive studies are needed to clarify the clinical relevance of these results. Keywords: Hyperlipidemia, Overweight, Hyperglycemia, Echocardiography, Myocardial infection</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s12872-022-02660-3</doi></addata></record>
fulltext fulltext
identifier ISSN: 1471-2261
ispartof BMC cardiovascular disorders, 2022-05, Vol.22 (1)
issn 1471-2261
1471-2261
language eng
recordid cdi_gale_infotracmisc_A703790406
source PubMed Central(OA); Publicly Available Content Database (ProQuest Open Access資料庫)
subjects Blood cell count
Body mass index
Cardiovascular research
Heart attack
Left ventricular function
Prognosis
title Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A33%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20cardiometabolic%20risk%20markers%20linked%20to%20reduced%20left%20ventricular%20ejection%20fraction&rft.jtitle=BMC%20cardiovascular%20disorders&rft.au=Mahdavi-Roshan,%20Marjan&rft.date=2022-05-14&rft.volume=22&rft.issue=1&rft.issn=1471-2261&rft.eissn=1471-2261&rft_id=info:doi/10.1186/s12872-022-02660-3&rft_dat=%3Cgale%3EA703790406%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g676-a6b1c9a9bddfd02afca44b73349524008b27adda174ad7393079d5fa7a2734913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A703790406&rfr_iscdi=true